Wells Fargo & Company MN Raises Stake in Omnicell, Inc. (NASDAQ:OMCL)

Wells Fargo & Company MN boosted its stake in Omnicell, Inc. (NASDAQ:OMCL) by 27.3% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 132,252 shares of the company’s stock after buying an additional 28,390 shares during the period. Wells Fargo & Company MN owned approximately 0.29% of Omnicell worth $5,888,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Smartleaf Asset Management LLC boosted its position in Omnicell by 51.5% in the 4th quarter. Smartleaf Asset Management LLC now owns 803 shares of the company’s stock valued at $35,000 after buying an additional 273 shares during the period. Van ECK Associates Corp raised its holdings in Omnicell by 47.0% during the fourth quarter. Van ECK Associates Corp now owns 985 shares of the company’s stock worth $44,000 after purchasing an additional 315 shares in the last quarter. Headlands Technologies LLC acquired a new position in Omnicell during the fourth quarter worth $53,000. First Horizon Advisors Inc. grew its position in Omnicell by 36.3% during the fourth quarter. First Horizon Advisors Inc. now owns 1,333 shares of the company’s stock worth $59,000 after buying an additional 355 shares during the period. Finally, Huntington National Bank boosted its position in Omnicell by 236.4% during the fourth quarter. Huntington National Bank now owns 1,359 shares of the company’s stock worth $61,000 after purchasing an additional 955 shares in the last quarter. Hedge funds and other institutional investors own 97.70% of the company’s stock.

Omnicell Stock Down 2.2 %

OMCL stock opened at $30.28 on Friday. Omnicell, Inc. has a fifty-two week low of $25.12 and a fifty-two week high of $55.75. The stock has a market cap of $1.42 billion, a PE ratio of 112.15, a price-to-earnings-growth ratio of 7.53 and a beta of 0.78. The firm’s 50-day simple moving average is $35.27 and its 200 day simple moving average is $41.27. The company has a quick ratio of 1.22, a current ratio of 1.37 and a debt-to-equity ratio of 0.13.

Omnicell (NASDAQ:OMCL) last released its earnings results on Thursday, February 6th. The company reported $0.45 earnings per share for the quarter, missing analysts’ consensus estimates of $0.57 by ($0.12). Omnicell had a return on equity of 3.82% and a net margin of 1.13%. As a group, sell-side analysts predict that Omnicell, Inc. will post 1.09 EPS for the current year.

Analyst Ratings Changes

OMCL has been the topic of a number of analyst reports. StockNews.com upgraded Omnicell from a “hold” rating to a “buy” rating in a report on Tuesday, April 15th. Bank of America dropped their target price on shares of Omnicell from $54.00 to $46.00 and set a “neutral” rating for the company in a research report on Monday, January 6th. Benchmark reiterated a “buy” rating and set a $62.00 target price on shares of Omnicell in a report on Tuesday, February 4th. Wells Fargo & Company reduced their price target on Omnicell from $40.00 to $38.00 and set an “equal weight” rating for the company in a report on Thursday. Finally, JPMorgan Chase & Co. cut their target price on shares of Omnicell from $44.00 to $36.00 and set a “neutral” rating on the stock in a research note on Thursday, March 20th. Four research analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. According to MarketBeat.com, Omnicell has a consensus rating of “Hold” and an average target price of $50.67.

Omnicell Company Profile

Omnicell, Inc, together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications.